Lecanemab and APOE Genotyping in Clinical Practice-Navigating Uncharted Terrain.
Sign Up to like & getrecommendations! Published in 2023 at "JAMA neurology"
DOI: 10.1001/jamaneurol.2023.0207
Abstract: This Viewpoint discusses the findings of the Clarity AD trial, which studied lecanemab for patients with early-stage Alzheimer disease. read more here.
Keywords: practice navigating; apoe genotyping; navigating uncharted; clinical practice ... See more keywords